Yew Bio-Pharm Group, Inc.
YEWB · OTC
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -2.1% | -25.8% | -7.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 12.9% | 2.8% | 28.5% | 12.5% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 17.5% | 4.3% | 52.6% | 8.2% |
| Net Income | $0 | $0 | -$0 | $0 |
| % Margin | 5.4% | 3.5% | -3.5% | 7.9% |
| EPS Diluted | 0.03 | 0.02 | -0.025 | 0.06 |
| % Growth | 50% | 178.7% | -142.3% | – |
| Operating Cash Flow | $0 | $0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |